Fig. 1
From: Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters
Effect of omega-3 fatty acid ethyl esters on FABP4 level (Study 1). a. Treatment with 4 g (2 g twice daily) omega-3 fatty acid ethyl esters, containing 1,860 mg/day eicosapentaenoic acid (EPA) ethyl ester and 1,500 mg/day docosahexaenoic acid (DHA) ethyl ester, for 4 weeks significantly decreased FABP4 levels in male patients with hypertriglycemia (n = 14). *P < 0.05. b-d. Changes (Post – Pre) in levels of EPA + DHA (b), EPA (c), DHA (d), total fatty acids (e) and triglycerides (f) were plotted against change in level of FABP4 for each subject